Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension

Trial Profile

Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension

Recruiting
Phase of Trial: Phase I

Latest Information Update: 14 May 2018

At a glance

  • Drugs Anakinra (Primary)
  • Indications Pulmonary arterial hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 May 2018 Planned End Date changed from 1 Apr 2019 to 1 Jul 2018.
    • 04 May 2018 Planned primary completion date changed from 1 Apr 2019 to 1 Jul 2018.
    • 18 May 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top